Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 8 Issue 3

Acceptance and Attitude Towards Human Papilloma Virus Vaccination Among Parents Attending Primary Health Care Centers, Riyadh, Saudi Arabia: A Cross-sectional Study

Nouf Mohammed Almansour1, Mezoun Almuhaimeed1, Nora Mohammed Albarakah2, Raghad Abdulaziz Alomaim1, Hussain Ali Almaklas3 and Mostafa Kofi1*

1Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia
2Specialized Medical Center (SMC), Riyadh, Saudi Arabia
3Ministry Oh Health (MOH), Khobar, Saudi Arabia

*Corresponding Author: Mostafa Kofi, Professor, Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia.

Received: February 16, 2024; Published: February 27, 2024

Abstract

Introduction: Human Papillomavirus (HPV) is a significant cause of cancers, with vaccines like Gardasil and Cervarix offering prevention. This study explored the attitude of parents in Riyadh towards HPV vaccination for their daughters, focusing on the factors that influence vaccine acceptance.

Methods: The study employed a cross-sectional design, using a structured questionnaire. The collected demographic details, knowledge about HPV and its vaccine, attitudes towards vaccination, and the factors influencing vaccination decisions. Participants were selected through convenience sampling at Primary Health Care centers across Riyadh, targeting parents of daughters aged 9-13 years.

Results: Among 380 participants, awareness regarding the HPV vaccine was 71.3%. Results showed that 46.1% of parents intended to vaccinate their daughters, 31.3% were undecided, and 22.6% were against it. Hesitancy factors included a lack of information (47.8%), concerns about side effects (21.5%), and absence of medical advice (21.0%). Statistical analysis showed a statistically significant differences in vaccine awareness by age (P < 0.001), with the highest awareness among the 25-35 years age group (81.4%) and the lowest in those over 55 (38.6% aware). Gender also played a role, with 78.2% of females versus 60.3% of males being aware of the vaccine (P = 0.001). Employment status correlated significantly with awareness (P < 0.001); 77.3% of employed respondents were aware of the HPV vaccine compared to 65.5% of unemployed respondents. Knowledge scores varied significantly, with an average score of 3.62 ± 2.50. Respondents with higher knowledge scores showed a stronger intention to vaccinate (r = 0.513, P < 0.001).

Conclusion: While a substantial proportion of parents in Riyadh are aware of the HPV vaccine, significant hesitancy exists, primarily due to informational deficits and safety concerns. The study underscores the need for targeted education campaigns to improve understanding of HPV vaccine benefits, addressing misconceptions and enhancing vaccine uptake to protect against HPV-related diseases.

 Keywords: Human Papillomavirus (HPV); Saudi Arabia

References

  1. Doorbar J., et al. “Human papillomavirus molecular biology and disease association”. Reviews in Medical Virology 25 (2015): 2-23.
  2. Michaud DS., et al. “High-risk HPV types and head and neck cancer”. International Journal of Cancer 135 (2014): 1653-1661.
  3. Gage JC., et al. “Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection”. International Journal of Cancer 136 (2015): 1665-1671.
  4. Hashim D., et al. “Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening”. British Journal of Cancer 122 (2020): 1715-1723.
  5. Ault KA. “Epidemiology and natural history of human papillomavirus infections in the female genital tract”. Infectious Diseases in Obstetrics and Gynecology (2006): 2006.
  6. Thornton C., et al. “Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients”. Thorax 77 (2022): 625-627.
  7. Kent A and Kirtley S. “Insights from outside BJOG”. BJOG: An International Journal of Obstetrics and Gynaecology 123 (2016): 493-497.
  8. Meites E., et al. “Human papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on Immunization Practices”. American Journal of Transplantation 19 (2019): 3202-3206.
  9. Bornstein J. “The HPV vaccine market: CervarixTM competes with Gardasil®”. Therapy 7 (2010): 71-75.
  10. Wasim PT. “Cervical Cancer Screening”. Annals of King Edward Medical University 23 (2017): 146-167.
  11. Tota JE., et al. “Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies”. Preventive Medicine (Baltim)1 (2011).
  12. Ardekani A., et al. “Human Papillomavirus Infection during Pregnancy and Childhood: A Comprehensive Review”. Microorganisms (2022): 10.
  13. Sankaranarayanan R., et al. “Current global status and impact of human papillomavirus vaccination: Implications for India”. Indian Journal of Medical Research 144 (2016): 169-180.
  14. Kamolratanakul S and Pitisuttithum P. “Human papillomavirus vaccine efficacy and effectiveness against cancer”. Vaccines (2021): 9.
  15. Shato T., et al. “Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states”. Vaccine 41 (2023): 3772-3781.
  16. Nguyen KH., et al. “Parental vaccine hesitancy and its association with adolescent HPV vaccination”. Vaccine 39 (2021): 2416-2423.
  17. Tursun S., et al. “Parent’s attitude and knowledge on HPV vaccination: A descriptive study”. Türk Hijyen ve Deneysel Biyoloji Dergisi 79 (2022): 409-418.
  18. Jin SW., et al. “Human Papillomavirus (HPV) Vaccination Knowledge, Beliefs, and Hesitancy Associated with Stages of Parental Readiness for Adolescent HPV Vaccination: Implications for HPV Vaccination Promotion”. Tropical Medicine and Infectious Disease (2023): 8.
  19. Munoz N and Jacquard A-C. “What should be known for the introduction of an HPV vaccine?” La Presse Médicale 37 (2008): 1377-1390.
  20. “Preventing multiple types of cancer through HPV vaccination”. Molecular Cancer Therapeutics (2011): 10.
  21. Saslow D., et al. “Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation”. CA: A Cancer Journal for Clinicians 70 (2020): 274-280.v
  22. Cocchio S., et al. “Awareness of HPV and drivers of HPV vaccine uptake among university students: A quantitative, cross-sectional study”. Health and Social Care in the Community 28 (2020): 1514-1524.
  23. Grigore M., et al. “Awareness and Knowledge About HPV and HPV Vaccine Among Romanian Women”. Journal of Cancer Education 33 (2018):154-159.
  24. Kudo R., et al. “Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection”. The Journal of Infectious Diseases 219 (2019): 382-390.
  25. Almehmadi MM., et al. “Awareness of human papillomavirus infection complications, cervical cancer, and vaccine among the saudi population: A cross-sectional survey”. Saudi Medical Journal 40 (2019): 555-559.
  26. Alrajeh MF and Alshammari SA. “Awareness of human papillomavirus and its vaccine among patients attending primary care clinics at king saud university medical city”. Journal of Natural Science, Biology and Medicine 3 (2020): 189-195.
  27. Walsh CD., et al. “Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination”. BMC Public Health (2008).
  28. YanRu Z., et al. “Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies”. BMC Public Health (2016): 16.
  29. Chido-Amajuoyi OG., et al. “Declining awareness of HPV and HPV vaccine within the general US population”. Human Vaccines and Immunotherapeutics 17 (2021): 420-427.
  30. López N., et al. “HPV knowledge and vaccine acceptability: a survey-based study among parents of adolescents (KAPPAS study)”. Infectious Agents and Cancer (2022): 17.
  31. Agénor M., et al. “Sex of Sexual Partners and Human Papillomavirus Vaccination Among U.S. Girls and Women”. American Journal of Preventive Medicine 50 (2016): 318-327.
  32. Farsi NJ., et al. “Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia”. Human Vaccines and Immunotherapeutics 17 (2021): 1968-1974.
  33. , et al. “Comparing knowledge and perceived risk related to the human papilloma virus among Australian women of diverse sexual orientations”. Australian and New Zealand Journal of Public Health 33 (2009): 87-93.

Citation

Citation: Mostafa Kofi., et al. “Acceptance and Attitude Towards Human Papilloma Virus Vaccination Among Parents Attending Primary Health Care Centers, Riyadh, Saudi Arabia: A Cross-sectional Study”.Acta Scientific Medical Sciences 8.3 (2024): 124-135.

Copyright

Copyright: © 2024 Mostafa Kofi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 20, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US